PARP Inhibition and Beyond in BRCA-Associated Breast Cancer in Women: A State-Of-The-Art Summary of Preclinical Research on Risk Reduction and Clinical Benefits - Pauwels, Ernest K.J.; Bourguignon, Michel H. (Medical principles and practice, 2022)
Keywords: Age; Breast cancer; Cancer therapies; Cell cycle; Chemotherapy; DNA damage; Mammography; Medical prognosis; Metastasis; Mutation; Proteins; Review; Synthetic lethality; BRCA1/2 mutation; PARP inhibitors; Female breast cancer; PARP inhibitor resistance